1Research on influential factors of innovative drugs development strategy in ChinaDIAO Yuan-yuan, WU Zhi-ang1409-14162Concerns of the genotoxicity evaluation of drugsGAO Mei, ZHANG Rong, XU Na, CHEN Kai, WANG Xin-xin, ZHANG Dai-zhou1417-14233Analysis of the current situation of bioequivalence trails of valsartan capsulesLIU Lu-yang, TIAN Li-juan1424-14284Current status and countermeasures of application of plant growth regulators in the cultivation of Chinese medicinal materialsAN Xiao-jing, LIU Shang-nian, GUO Hao, LI Xian-en, WANG Yan-ting, GUAN Min, GUO Bao-lin, CHEN Cai-xia1429-14365Analysis on the key points of production quality supervision of the first nasal spray COVID-19 vaccine in ChinaLIU Jing-jing, ZHANG Lai-jun, FU Fei, LI Min, LI Yu-li, HE Huan, WANG Qian-shuo, DONG Chen-di, YE Xiang-zhong, JIANG Jin-qi, LI Wen-dong1437-14416Mechanism and preclinical evaluation of cytokine release syndrome induced by monoclonal antibodiesFU Ying-shuang, LI Shuang-xing, JIANG Hua, LIN Zhi1442-14487Progress in oral soluble film for prevention and treatment of nausea and vomitingZHAO Bo-yuan, LI Na, WANG Meng, REN Xiao-liang1449-14578Applications of new approach methodologies in new drug research and developmentWANG Chun-ming, NIU Zhang-ming, ZHANG Long1458-14659Pharmacodynamic and pharmacokinetic studies of a novel KRASG12C inhibitor VT198WANG Mei-qing, BAI Hu-cheng, ZHANG Shu, LI Xiao-chuan, WANG Ting-chun, DUAN Xiao-qun1466-147110Evaluation of key production process of Baoyuan Decoction Granules based on characteristic chromatograms and quantitative transfer relationshipLI Na, DIAO Yuan-yuan, LIU Wei-peng, SHI Yu-wen, JIANG Meng-cheng, LI Jun-ge, QIU Zhi-dong, JIA Ai-ling1472-148111Standardization of the first batch of national reference standard of agomelatineSUN Chang-ying, WEN Qiang, ZHANG Yan-xia, YIN Li-hui1482-148812Study on the yield stress measurement methods of two kinds of semi-solid preparations for external skin useLIU Chao-yi, GAO Xuan, WANG Lin-bo, CHEN Xiao-ping, QIN feng, WU Xiao-luan1489-149513Analysis of concentration and similarity of antimicrobial agent use in ChinaYU Jun-xuan, YANG Yao-yao, ZHANG Wan-meng, DU Ke-xin, HU Lin, Weihsin Ko, HUANG Xian-qin, ZHENG Bo, GUAN Xiao-dong, Haishaerjiang·Wushouer, SHI Lu-wen1496-150314Pharmacoeconomic evaluation for peripheral T-cell lymphoma:a systematic reviewMAO Xin, LU Yu-qiong, DAI Zhan-jing, CUI Xiang-yu, CHEN Kai, REN Ting, LU Yun, CHANG Feng1504-151315Literature analysis of thromboembolic events caused by immune checkpoint inhibitorYIN Yue-song, WU Yu-pei, ZHANG Li-na, ZHAO Jian-qun1514-1520